Renaissance Technologies’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.45M Buy
656,047
+78,900
+14% +$817K 0.01% 1336
2025
Q4
$7.13M Buy
577,147
+58,900
+11% +$631K 0.01% 1095
2025
Q3
$4.57M Sell
518,247
-171,400
-25% -$1.33M 0.01% 1559
2025
Q2
$4.4M Sell
689,647
-70,600
-9% -$404K 0.01% 1601
2025
Q1
$3.69M Buy
760,247
+94,400
+14% +$781K 0.01% 1606
2024
Q4
$6.37M Buy
665,847
+140,900
+27% +$1.29M 0.01% 1292
2024
Q3
$4.38M Buy
524,947
+351,200
+202% +$3.19M 0.01% 1530
2024
Q2
$1.18M Sell
173,747
-717,553
-81% -$3.09M ﹤0.01% 2227
2024
Q1
$2.25M Buy
891,300
+344,000
+63% +$775K ﹤0.01% 1954
2023
Q4
$1.31M Buy
+547,300
New +$1.29M ﹤0.01% 2222
2023
Q1
Sell
-304,000
Closed -$3.59M 4067
2022
Q4
$3.59M Buy
304,000
+248,900
+452% +$3.85M ﹤0.01% 1709
2022
Q3
$1.16M Sell
55,100
-39,900
-42% -$1.11M ﹤0.01% 2403
2022
Q2
$2.95M Sell
95,000
-263,000
-73% -$8.98M ﹤0.01% 1913
2022
Q1
$14.7M Buy
+358,000
New +$15.8M 0.02% 915
2021
Q1
Sell
-62,100
Closed -$5.56M 3405
2020
Q4
$5.56M Buy
62,100
+17,996
+41% +$1.65M 0.01% 1517
2020
Q3
$4.56M Sell
44,104
-340,520
-89% -$36.7M ﹤0.01% 1628
2020
Q2
$30.4M Sell
384,624
-238,377
-38% -$17.8M 0.03% 604
2020
Q1
$36M Sell
623,001
-141,100
-18% -$8.13M 0.04% 491
2019
Q4
$41.2M Sell
764,101
-220,210
-22% -$11.9M 0.03% 612
2019
Q3
$51.5M Sell
984,311
-366,200
-27% -$17.1M 0.04% 495
2019
Q2
$65.2M Sell
1,350,511
-627,891
-32% -$30.1M 0.06% 387
2019
Q1
$99.9M Buy
1,978,402
+382,391
+24% +$22.6M 0.09% 253
2018
Q4
$94.6M Sell
1,596,011
-275,300
-15% -$17.7M 0.1% 225
2018
Q3
$123M Sell
1,871,311
-195,200
-9% -$11.4M 0.13% 171
2018
Q2
$104M Buy
2,066,511
+198,600
+11% +$10.3M 0.11% 191
2018
Q1
$98.3M Buy
1,867,911
+283,000
+18% +$14.1M 0.11% 200
2017
Q4
$73.7M Buy
1,584,911
+432,300
+38% +$18.2M 0.08% 288
2017
Q3
$46.6M Buy
1,152,611
+332,200
+40% +$12M 0.05% 448
2017
Q2
$27.8M Buy
820,411
+117,700
+17% +$3.63M 0.04% 659
2017
Q1
$20.4M Sell
702,711
-180,800
-20% -$5.5M 0.03% 787
2016
Q4
$29M Sell
883,511
-294,600
-25% -$8.83M 0.05% 555
2016
Q3
$37.1M Sell
1,178,111
-96,100
-8% -$2.79M 0.07% 393
2016
Q2
$35.8M Buy
1,274,211
+161,400
+15% +$6.33M 0.07% 376
2016
Q1
$40.5M Buy
1,112,811
+161,200
+17% +$5.69M 0.08% 310
2015
Q4
$38.1M Buy
951,611
+177,400
+23% +$6.19M 0.08% 286
2015
Q3
$22.1M Buy
774,211
+102,700
+15% +$3.38M 0.05% 459
2015
Q2
$22.1M Buy
671,511
+84,700
+14% +$2.63M 0.05% 484
2015
Q1
$16.9M Buy
586,811
+75,700
+15% +$2.17M 0.04% 667
2014
Q4
$13.9M Sell
511,111
-28,300
-5% -$674K 0.03% 689
2014
Q3
$11.5M Sell
539,411
-68,100
-11% -$1.56M 0.03% 683
2014
Q2
$13.6M Sell
607,511
-155,387
-20% -$3.62M 0.03% 666
2014
Q1
$19.3M Buy
762,898
+199,287
+35% +$5.03M 0.05% 501
2013
Q4
$13M Sell
563,611
-33,900
-6% -$707K 0.03% 666
2013
Q3
$11.4M Sell
597,511
-126,300
-17% -$2.25M 0.03% 739
2013
Q2
$10.4M Buy
+723,811
New +$10.5M 0.03% 711

Other funds holding EBS